Skip to main content
. 2013 Jul 30;10(9):1209–1216. doi: 10.7150/ijms.5508

Table 1.

Patient characteristics

Parameter Total Cilnidipine Amlodipine
N
Male
Age (years)
Height (cm)
Body weight (kg)
BMI (m2/kg)
Dyslipidemia
Organ damage
Cerebrovascular disease
Diabetic neuropathy
Diabetic retinopathy
Myocardial infarction
Angina pectoris
Heart failure
Arteriosclerosis obliterans
365
240 (65.8%)
63.84 ± 8.46
160.55 ± 9.07
66.87 ± 12.93
25.84 ± 3.91
179 (49.0%)
55 (15.1%)
20 (5.5%)
49 (13.4%)
39 (10.7%)
12 (3.3%)
13 (3.6%)
7 (1.9%)
9 (2.5%)
179
112 (62.6%)
63.27 ± 8.72
160.86 ± 9.49
68.31 ± 14.52
26.27 ± 4.34
87 (48.6%)
32 (17.9%)
11 (6.1%)
26 (14.5%)
22 (12.3%)
6 (3.4%)
8 (4.5%)
4 (2.2%)
5 (2.8%)
186
128 (68.8%)
64.39 ± 8.19
160.40 ± 8.70
65.48 ± 11.05
25.42 ± 3.41
92 (49.5%)
23 (12.4%)
9 (4.8%)
23 (12.4%)
17 (9.1%)
6 (3.2%)
5 (2.7%)
3 (1.6%)
4 (2.2%)

Data are shown as the no. of patients (%) or the mean ± SD. Abbreviations: BMI: body mass index